US FDA chief blames 'crazy quilt' of legal powers for compounding debacle
This article was originally published in Scrip
Executive Summary
The head of a Massachusetts pharmacy whose contaminated compounded products triggered a nationwide fungal meningitis outbreak refused to answer questions before members of Congress on 14 November – invoking his constitutional rights to remain silent – while the head of the US FDA got into a heated exchange with lawmakers over her agency's failure in preventing the crisis.